---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-025200"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T13:25:58.761124+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# National Research Q3 revenue up 13% to $37.8M; EPS $0.38 vs $0.37

## Summary
- Revenue $37.8M (+13% YoY); operating income $13.1M (+9%).
- Recurring Contract Value $151.5M; Voice of Customer revenue up 20%.
- Net income $9.7M vs $9.6M; diluted EPS $0.38 vs $0.37.
- Cash balance $52.5M; new clients Sharp Healthcare and UConn Health.

## SEC filing metadata
- accession: 0001437749-21-025200
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774921025200/0001437749-21-025200-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774921025200/nrc20211102_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-025200
- JSON: https://secwatch.observer/filing/0001437749-21-025200.json
- Plain text: https://secwatch.observer/filing/0001437749-21-025200.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.